Emerging markets such as China, India, and Japan are the key areas of opportunity for players in this market. However, stringent clinical & regulatory processes and unfavorable healthcare reforms in the US are expected to restrain the growth of this market during the forecast period.
Factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases are driving the growth of the market.
The global biomaterials market is projected to reach $207 billion by 2024 from $105 billion in 2019, at a CAGR of 14.5% between 2019 and 2024.
Metallic biomaterials accounted for the largest share of the biomaterials market in 2018
The metallic biomaterials segment accounted for the largest share of the biomaterials market, by type, in 2018. This is primarily attributed to the wide use of metals in the manufacturing of medical devices used in cardiovascular, dental, and orthopedic applications. It is expected that the rise in geriatric population globally will increase the demand for these devices, as age increases susceptibility to orthopedic, dental, ophthalmological, neurological, and cardiovascular disorders. In line with this, according to the American Joint Replacement Registry (AJRR), 860,080 hip and knee replacement procedures were performed in the US in 2017. This number is expected to reach 3.48 million procedures per year by 2030.
Download PDF Brochure - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=393
Cardiovascular applications segment accounted for the largest share of the biomaterials market in 2018
The cardiovascular applications segment accounted for the largest share of the biomaterials market, by application, in 2018. This is primarily due to the increasing prevalence of cardiovascular diseases, rising geriatric population, growing number of angiography procedures, and the increasing adoption of cardiac stents, pacemakers, and implantable cardiac defibrillators. For instance, according to the World Health Organization (WHO), 17.9 million people die each year from CVDs, which is an estimated 31% of all deaths worldwide. This figure is expected to grow to more than 23.6 million by 2030. Additionally, a number of diagnostic and therapeutic devices have been developed for cardiac applications. These devices include catheters, guidewires, sensors, pacemakers, implantable cardioverter defibrillators, vascular grafts, heart valves, and stents. Biomaterials are used for the manufacturing of these devices.
Request for Sample Pages - https://www.marketsandmarkets.com/requestsampleNew.asp?id=393
Asia Pacific region to register the highest growth in the biomaterials market during the forecast period
In 2018, North America accounted for the largest share of the biomaterials market, followed by Europe. Increase in biomaterial-based research, rising demand for plastic surgeries, growing incidence of cancer, and the rising prevalence of cardiovascular diseases are the factors propelling the growth of the biomaterials market in this region.
The Asia Pacific region is projected to register the highest growth rate in the biomaterials market during the forecast period, primarily due to the rising geriatric population in China and India, Japan’s growing healthcare industry, and the rising prevalence of cardiovascular diseases in India.
Leading Companies
Prominent players in the biomaterials market are Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Carpenter Technology Corporation (US), Evonik Industries (Germany), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), Celanese Corporation (US), CoorStek Inc. (US), CeramTec (Germany), and GELITA AG (Germany).
Don’t miss out on business opportunities in Biomaterials Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
